A detailed history of Wetherby Asset Management Inc transactions in Argenx Se stock. As of the latest transaction made, Wetherby Asset Management Inc holds 1,357 shares of ARGX stock, worth $847,012. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,357
Previous 1,277 6.26%
Holding current value
$847,012
Previous $549,000 33.88%
% of portfolio
0.03%
Previous 0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$434.22 - $551.9 $34,737 - $44,152
80 Added 6.26%
1,357 $735,000
Q2 2024

Aug 14, 2024

SELL
$356.01 - $451.55 $61,589 - $78,118
-173 Reduced 11.93%
1,277 $549,000
Q1 2024

May 15, 2024

BUY
$356.95 - $413.29 $36,408 - $42,155
102 Added 7.57%
1,450 $570,000
Q4 2023

Feb 14, 2024

SELL
$338.91 - $506.01 $26,434 - $39,468
-78 Reduced 5.47%
1,348 $512,000
Q3 2023

Nov 14, 2023

BUY
$369.35 - $548.43 $56,510 - $83,909
153 Added 12.02%
1,426 $701,000
Q2 2023

Aug 14, 2023

BUY
$360.14 - $422.58 $15,125 - $17,748
42 Added 3.41%
1,273 $496,000
Q1 2023

May 12, 2023

SELL
$334.23 - $403.65 $42,447 - $51,263
-127 Reduced 9.35%
1,231 $458,000
Q4 2022

Feb 14, 2023

BUY
$342.17 - $402.31 $12,660 - $14,885
37 Added 2.8%
1,358 $514,000
Q3 2022

Nov 14, 2022

BUY
$343.2 - $395.75 $25,740 - $29,681
75 Added 6.02%
1,321 $466,000
Q2 2022

Aug 15, 2022

BUY
$269.58 - $378.88 $126,433 - $177,694
469 Added 60.36%
1,246 $472,000
Q1 2022

May 16, 2022

BUY
$254.45 - $351.06 $5,343 - $7,372
21 Added 2.78%
777 $245,000
Q4 2021

Feb 14, 2022

BUY
$272.01 - $353.03 $23,936 - $31,066
88 Added 13.17%
756 $265,000
Q3 2021

Nov 15, 2021

BUY
$295.0 - $350.58 $197,060 - $234,187
668 New
668 $202,000
Q2 2021

Aug 16, 2021

SELL
$257.11 - $319.92 $220,857 - $274,811
-859 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$268.3 - $380.31 $39,171 - $55,525
146 Added 20.48%
859 $237,000
Q4 2020

Feb 11, 2021

BUY
$248.13 - $308.36 $176,916 - $219,860
713 New
713 $210,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.5B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Wetherby Asset Management Inc Portfolio

Follow Wetherby Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.